Resveratrol exhibited anti-IBS-like effects on depression, stress, and intestinal motility abnormalities by regulating 5-HT-dependent PKA–CREB–BDNF signaling in the brain–gut axis [125]. The gene discussed is CREB1; the disease is irritable bowel syndrome.